Literature DB >> 28584933

Reply to: MASCC/ESMO consensus recommendations for the management of nausea and vomiting in advanced cancer.

S I R Noble1, F E M Murtagh2, Claudia Bausewein3, Miriam J Johnson4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28584933     DOI： 10.1007/s00520-017-3767-8

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  6 in total

1.  Guidelines International Network: toward international standards for clinical practice guidelines.

Authors:  Amir Qaseem; Frode Forland; Fergus Macbeth; Günter Ollenschläger; Sue Phillips; Philip van der Wees
Journal:  Ann Intern Med       Date:  2012-04-03       Impact factor: 25.391

Review 2.  2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer.

Authors:  Declan Walsh; Mellar Davis; Carla Ripamonti; Eduardo Bruera; Andrew Davies; Alex Molassiotis
Journal:  Support Care Cancer       Date:  2016-08-17       Impact factor: 3.603

3.  Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction.

Authors:  David C Currow; Stephen Quinn; Meera Agar; Belinda Fazekas; Janet Hardy; Nikki McCaffrey; Simon Eckermann; Amy P Abernethy; Katherine Clark
Journal:  J Pain Symptom Manage       Date:  2014-11-14       Impact factor: 3.612

Review 4.  Somatostatin Analogues Compared With Placebo and Other Pharmacologic Agents in the Management of Symptoms of Inoperable Malignant Bowel Obstruction: A Systematic Review.

Authors:  George P Obita; Elaine G Boland; David C Currow; Miriam J Johnson; Jason W Boland
Journal:  J Pain Symptom Manage       Date:  2016-09-30       Impact factor: 3.612

5.  Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study.

Authors:  Pascale Mariani; Joëlle Blumberg; Alain Landau; Daniela Lebrun-Jezekova; Estelle Botton; Olivier Beatrix; Didier Mayeur; Robert Herve; Pascal Maisonobe; Laure Chauvenet
Journal:  J Clin Oncol       Date:  2012-10-29       Impact factor: 44.544

6.  Feeling validated versus being correct: a meta-analysis of selective exposure to information.

Authors:  William Hart; Dolores Albarracín; Alice H Eagly; Inge Brechan; Matthew J Lindberg; Lisa Merrill
Journal:  Psychol Bull       Date:  2009-07       Impact factor: 17.737
  6 in total
  1 in total

1.  Development of a core outcome set to use in the research and assessment of malignant bowel obstruction: protocol for the RAMBO study.

Authors:  Elin Baddeley; Alison Bravington; Miriam Johnson; David C Currow; Fliss Em Murtagh; Elaine Boland; George Obita; Annmarie Nelson; Kathy Seddon; Alfred Oliver; Simon Noble; Jason Boland
Journal:  BMJ Open       Date:  2020-06-28       Impact factor: 2.692
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.